Navigation Links
Next Silicon Valley BioTalks Tackles “Is EDC Becoming a Commodity?” at Onyx Pharmaceuticals HQ
Date:4/9/2013

errors and speeds up the overall trial process, reducing clinical research costs by up to 20%.
Despite the benefits, adoption of EDC systems has remained slow. By December 2012, only 40% of Phase I clinical trials utilized EDC. How can these low adoption rates be explained? Do the currently-available EDC systems effectively meet sponsor companies’ needs?

Event details:
Wednesday, April 17, 2013
5.30pm – 8.00pm PDT

Onyx Pharmaceuticals
249 East Grand Avenue
South San Francisco, California 94080

Register for free before April 12, 2013: clinovo.com/biotalks

Click here to read panelists' bios

  •     Eric Morrie, Manager, Clinical Programming at Onyx Pharmaceuticals
  •     Dr. Omar Dawood, M.D., M.P.H., Visionary Senior Executive and Clinical Leader
  •     Marc Desgrousilliers, Chief Technology Officer at Clinovo
  •     Moderated by Dr. Bob Molinari, Ph.D., C.E.O. at Retrotope & Partner at MedStars

About the Silicon Valley BioTalks
The Silicon Valley BioTalks is a quarterly series of free panel discussions, sponsored by Clinovo, for life science professionals looking to streamline their clinical trials. Representatives from leading pharmaceutical, biotechnology, and medical device companies share expertise and best practices about hot topics in the industry.
Read about the latest sessions on clinovo.com/biotalks

Read the full story at http://www.prweb.com/releases/2013/4/prweb10613870.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Galectin Therapeutics: Turning Atlanta into Americas Next Silicon Valley
2. Building quantum states with individual silicon atoms
3. New material interface improves functioning of non-silicon-based electronic devices
4. New world record efficiency for thin film silicon solar cells
5. Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show
6. Rigaku Publishes Application Note for Accurate Quantitative Analysis of Ferrosilicon by the Fusion Method Using ZSX Primus III+
7. Tiny compound semiconductor transistor could challenge silicons dominance
8. Flexible silicon solar-cell fabrics may soon become possible
9. Fabrication on patterned silicon carbide produces bandgap to advance graphene electronics
10. Rice team boosts silicon-based batteries
11. Aviir Diagnostic Laboratories Secures $8 Million In Funding From Silicon Valley Bank
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 30, 2015 ... reports results for the second quarter of 2015. ... group,s results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics ... Q2 results - Performance drivers ...
(Date:7/29/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today ... Financial Officer has resigned.  The Company has hired ... retired in December 2014, as full time interim CFO ... Andy Ashworth began his employment ... smooth transition.  Andy was the Company,s CFO from September ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... today announced its GHS Label Guide . To align chemical container labeling ... this guide includes explanations of label components, an example of an accurate label, ...
(Date:7/29/2015)... ... July 29, 2015 , ... The third Medical Innovation ... combination products , in particular, drug/device combinations. The current system received a score of ... Initiative for Patient Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ) ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Brady Announces a New GHS Label Guide 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3
... Sept. 15 BioMed Realty Trust, Inc.,(NYSE: BMR ) ... quarter 2008 dividend of $0.335 per share of common stock. ... common share., BioMed also announced that its board of ... company,s 7.375% Series A Cumulative,Redeemable Preferred Stock for the period ...
... (NYSE: SYK ) announced that it will host ... p.m., Eastern Time, to discuss the,Company,s operating results for ... update. Operating results for the quarter ended,September 30, 2008 ... To participate in the conference call dial 800-299-9630 (domestic) ...
... Fougera, a division of Nycomed,US Inc., today announced ... The generic formulation compares to Taro,s Referenced Listed ... tubes (NDC # 0168-0133-15), 30g tubes,(NDC # 0168-0133-30) ... approval of Clotrimazole Cream is another illustration of,Fougera,s ...
Cached Biology Technology:BioMed Realty Trust Declares Third Quarter 2008 Common Stock and Preferred Stock Dividends 2Stryker to Host Conference Call on October 16, 2008 2
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
(Date:6/30/2015)... To bolster its efforts and commitment to fighting cyber fraud, ... of two new team members. Dimitri ... Raviv will act as head of strategic alliances. These ... the most secure solutions for the enterprise market. ... a provider of security and management products, which was acquired ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... The International HapMap Project was initiated with the primary ... basis for human diseases. To coordinate with the ... journal Genome Research is announcing a special ... to studies using these data to provide insight into ...
... with the primary goal of facilitating medical studies and ... coordinate with the journal Nature 's publication describing ... announcing a special issue entitled "Human Genome Variation," which ... provide insight into human biology and disease. , ...
... drug designAs part of a $4.88 million grant from ... University of Rochester Medical Center will join a team ... a living cell. By wiring diagram, researchers mean a ... their function, but also of the interplay between them. ...
Cached Biology News:Housecat-sized Siberian tiger cubs get collared 2Housecat-sized Siberian tiger cubs get collared 3Housecat-sized Siberian tiger cubs get collared 4Studies on human genome variation provide insight into disease 2Studies on human genome variation provide insight into disease 3Studies on human genome variation provide insight into disease 4New study to explore cellular circuitry 2New study to explore cellular circuitry 3
SHEEP ANTI DEHYDROEPIANDROSTERONE...
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure Grade DAPI is greater than or equal to 98% pure by HPLC....
... A.D. Smith et.al. (1997) • ... on current biochemistry & molecular ... 17,000 headwords. Entries give details ... processes in which they are ...
... • This book describes the basic ... preparing samples for protein transfer and ... bioluminescence-enhanced detection systems are also included. ... and characterization of glycoprotein carbohydrate chains ...
Biology Products: